CELESTICA INC (CLS) Forecast, Price Target & Analyst Ratings

NYSE:CLSCA15101Q2071

Current stock price

279.018 USD
-2.93 (-1.04%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CELESTICA INC (CLS).

Forecast Snapshot

Consensus Price Target

Price Target
$270.25
-3.14% Downside

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 22, 2026
Period
Q1 / 2026
EPS Estimate
$2.08
Revenue Estimate
3.99B

ChartMill Buy Consensus

Rating
81.18%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$270.25
Upside
-3.14%
From current price of $279.02 to mean target of $270.25, Based on 17 analyst forecasts
Low
$129.75
Median
$297.80
High
$329.55

Price Target Revisions

1 Month
-0.20%
3 Months
8.39%

Price Target Summary

17 Wall Street analysts provided a forecast for the next 12 months for CLS. The average price target is 270.25 USD. This implies a price decrease of -3.14% is expected in the next year compared to the current price of 279.018.
The average price target has been revised upward by 8.39% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

CLS Current Analyst RatingCLS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

CLS Historical Analyst RatingsCLS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
81.18%
CLS was analyzed by 17 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about CLS.
In the previous month the buy percentage consensus was at a similar level.
CLS was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-11CIBCMaintains Outperformer -> Outperformer
2026-01-30BarclaysMaintains Overweight -> Overweight
2026-01-30CitigroupMaintains Buy -> Buy
2025-11-14BarclaysMaintains Overweight -> Overweight
2025-11-10CitigroupUpgrade Neutral -> Buy
2025-10-29CIBCMaintains Outperformer -> Outperformer
2025-10-29UBSMaintains Neutral -> Neutral
2025-10-29RBC CapitalMaintains Outperform -> Outperform
2025-10-29StifelReiterate Buy -> Buy
2025-10-29BarclaysMaintains Overweight -> Overweight
2025-10-29JP MorganMaintains Overweight -> Overweight
2025-10-29TD SecuritiesMaintains Hold -> Hold
2025-10-29Goldman SachsMaintains Buy -> Buy
2025-10-22RBC CapitalMaintains Outperform -> Outperform
2025-10-20CIBCMaintains Outperformer -> Outperformer
2025-10-16Goldman SachsInitiate Buy
2025-10-03TD CowenReiterate Hold
2025-10-03TD SecuritiesDowngrade Buy -> Hold
2025-09-08JP MorganMaintains Overweight -> Overweight
2025-08-19CICCInitiate Outperform
2025-07-30UBSMaintains Neutral -> Neutral
2025-07-30RBC CapitalMaintains Outperform -> Outperform
2025-07-30BarclaysMaintains Overweight -> Overweight
2025-07-30Canaccord GenuityMaintains Buy -> Buy
2025-07-30CitigroupMaintains Neutral -> Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 22, 2026
Period
Q1 / 2026
EPS Estimate
$2.08
Revenue Estimate
3.99B
Revenue Q2Q
50.65%
EPS Q2Q
73.47%
Number of Analysts
13

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
10.31%
EPS (1 Month)
0.00%
EPS (3 Months)
13.82%

Next Earnings Summary

CLS is expected to report earnings on 4/22/2026. The consensus EPS estimate for the next earnings is 2.08 USD and the consensus revenue estimate is 3.99B USD.
The next earnings revenue estimate has been revised upward by 10.31% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
CLS revenue by date.CLS revenue by date.
7.961B
9.81%
9.646B
21.17%
12.391B
28.46%
17.57B
41.80%
24.59B
39.95%
31.365B
27.55%
EBITDA
YoY % growth
CLS ebitda by date.CLS ebitda by date.
481.2M
16.01%
720.2M
49.67%
1.246B
73.02%
1.608B
29.04%
2.303B
43.22%
3.693B
60.36%
EBIT
YoY % growth
CLS ebit by date.CLS ebit by date.
350.4M
29.78%
568.3M
62.19%
1.07B
88.35%
1.38B
28.92%
1.991B
44.28%
2.574B
29.28%
Operating Margin
CLS operating margin by date.CLS operating margin by date.
4.40%5.89%8.64%7.85%8.10%8.21%
EPS
YoY % growth
CLS eps by date.CLS eps by date.
2.43
27.23%
3.92
61.32%
6.06
54.59%
9.00
48.55%
12.97
44.05%
16.95
30.73%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
2.08
73.47%
2.14
54.26%
2.21
39.91%
2.40
26.90%
2.51
20.57%
2.70
26.00%
2.99
35.47%
3.26
35.91%
Revenue
Q2Q % growth
3.99B
50.65%
4.207B
45.40%
4.229B
32.40%
4.47B
22.30%
4.758B
19.25%
5.09B
20.99%
5.55B
31.24%
5.944B
32.98%
EBITDA
Q2Q % growth
376.88M
104.49%
385.44M
23.34%
365.49M
-6.67%
389.12M
-21.63%
422.79M
12.18%
452.13M
17.30%
491.06M
34.36%
523.53M
34.54%
EBIT
Q2Q % growth
318.19M
116.60%
327.31M
42.43%
327.12M
21.79%
348.73M
8.71%
381.73M
19.97%
408.04M
24.66%
444.96M
36.02%
475.91M
36.47%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CLS Yearly Revenue VS EstimatesCLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B
CLS Yearly EPS VS EstimatesCLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
40.90%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
36.42%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
58.82%
EBIT Next 5 Year
N/A

CELESTICA INC / CLS Forecast FAQ

What do analysts expect the price target to be for CELESTICA INC (CLS)?

17 analysts have analysed CLS and the average price target is 270.25 USD. This implies a price decrease of -3.14% is expected in the next year compared to the current price of 279.018.

When does CELESTICA INC (CLS) report earnings?

CELESTICA INC (CLS) will report earnings on 2026-04-22.

What are the consensus estimates for CLS stock next earnings?

The consensus EPS estimate for the next earnings of CELESTICA INC (CLS) is 2.08 USD and the consensus revenue estimate is 3.99B USD.

What is the expected long term growth rate for CELESTICA INC (CLS)?

The expected long term growth rate for CELESTICA INC (CLS) is 36.42%.